Skip to content

Role of zinc supplementation in promoting recovery from acute bronchiolitis (a viral respiratory tract infection) in children.

ZINC SUPPLEMENTATION FOR SEVERE BRONCHIOLITIS: A RANDOMIZED CONTROLLED STUDY

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/07/001864
Enrollment
100
Registered
2011-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J219- Acute bronchiolitis, unspecified Health Condition 2: null- Bronchiolitis

Interventions

Intervention1: oral zinc: 10 mg/day for children 6 months
20 mg/day for children 6 months Duration: 7 days Control Intervention1: Placebo: Identically looking and packaged inert tablets for 7 days

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children (between 3 months to 2 years) with a clinical diagnosis of severe bronchiolitis (inability to feed, severe distress,apnea, hypoxemia, lethargy or cyanosis)

Exclusion criteria

Exclusion criteria: 1) They were receiving or had received any micronutrient supplementation within last 4 weeks prior to onset of present illness. 2) Clinical evidence of underlying cardiac or chronic pulmonary disease 3) There is a co-morbid condition (severe malnutrition, meningitis) present at the time of admission. 4) There is lobar consolidation in chest x-ray. 5) Intubation/ventilation is required before enrolment.

Design outcomes

Primary

MeasureTime frame
1. Resolution of severe bronchiolitis (when lower chest retraction and the danger signs are no longer present) 2. Time to resolution of lower chest indrawing, fast breathing, inability to feed Timepoint: 7 days

Secondary

MeasureTime frame
1. Recovery rate (proportion of children with resolution of severe bronchiolitis) 2. Duration of oxygen therapy 3. Duration of IV fluids 4. Duration of hospitalization Timepoint: 7 days

Countries

India

Contacts

Public ContactDr Dheeraj Shah

Department of Pediatrics, University College of Medical Sciences and Guru Tegh Bahadur Hospital

shahdheeraj@hotmail.com09868399792

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026